Clinical trials
Terminated Osteoporosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 66 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Merck Sharp & Dohme LLC | 3 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2 |
| AO Clinical Investigation and Publishing Documentation | 1 |
| Amgen | 1 |
| Antonio Lazzari | 1 |
| Bone Index Finland Ltd | 1 |
| Bugra Ince | 1 |
| Canadian Urology Research Consortium | 1 |
| Centre Hospitalier Régional d'Orléans | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoporosis | 66 |
| Bone Diseases, Metabolic | 11 |
| Hip Fractures | 5 |
| Diabetes Mellitus | 4 |
| Spinal Cord Injuries | 4 |
| Arthritis, Rheumatoid | 3 |
| Fractures, Bone | 3 |
| Osteoporotic Fractures | 3 |
| Cardiovascular Diseases | 2 |
| Inflammation | 2 |
Trials
Showing 51 to 66 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.